Current research provides limited understanding about the clonal advantage of identified mutations in aCML, and further investigation is required to elucidate the clonal mechanisms of ASXL1, SETBP1, NRAS, and CSF3R gene mutations in relation to aCML progression and transformation. Here, CSF3R is linked to atypical chronic myeloid leukemia, BCR-ABL1 negative.